مركز رحم للخصوبة
Prof. Eman A. Elgindy

Prof. Eman A. ElgindyMD, PhD

Founder & Chair of Rahem Fertility Centers — Professor of Obstetrics & Gynaecology and Consultant in Reproductive Medicine

published research papers
30+
international conference talks
100+
international books
2
years in medicine
35+
  • PhD in Reproductive Medicine — Maastricht University, the Netherlands, supervised by Prof. Hans Evers
  • Founder and Chair of the Board of Trustees, Egyptian Foundation for Reproductive Medicine and Embryology (EFRE)
  • Director of the Egypt IVF Registry and co-author of the ICMART world reports on assisted reproduction
  • Speaker at the ASRM Scientific Congress (USA), 2025 and 2026
  • Best Research in Human Reproduction Award — Middle East Fertility Society (MEFS), 2008

Academic profiles:ORCIDPubMedICMARTResearchGateLinkedIn

From global expertise to Rahem

In fertility care, real expertise isn't only years in practice or the number of cases treated. It starts with scientific training — exposure to the world's leading medical and research schools, and learning from the scientists who shaped the field.

On 13 November 2013, Prof. Eman A. Elgindy earned her PhD in Reproductive Medicine from Maastricht University in the Netherlands, with the thesis “Long GnRH agonist protocol in IVF: approaches to optimizing treatment outcome” — one of the central questions in fertility treatment: how to improve IVF results by choosing the right protocol for each patient.

Her principal supervisor was Prof. J.L.H. (Hans) Evers of Maastricht University, one of the most prominent figures in reproductive medicine: former Editor-in-Chief of Human Reproduction — one of the field's leading journals — and former Chairman of the European Society of Human Reproduction and Embryology (ESHRE).

Training under a scientist of that stature shapes more than knowledge; it shapes how one thinks: how evidence is weighed, how research is designed and analysed, how results become better clinical decisions — and how every case of delayed conception deserves an individual plan rather than one protocol for everyone.

That training didn't end with the PhD. Prof. Elgindy has stayed closely connected to the international scientific community — through congresses and societies worldwide — bringing the latest in assisted reproduction, embryo transfer, implantation failure and poor ovarian response back to patients in Egypt. That is Rahem's philosophy: the best care starts with the best science, and is complete only when global expertise becomes real care for every patient.

Research focus

  • Frozen embryo transfer optimisation and endometrial preparation
  • Recurrent implantation failure
  • Individualised ovarian stimulation and poor responders
  • Fertility preservation in women with cancer
  • Luteal phase support
  • Ovarian reserve and AMH

Publications

Research in leading international reproductive-medicine journals, including randomised controlled trials and global IVF registry reports.

Selected publications

  1. International report2026

    The International Glossary on Infertility and Fertility Care, 2025

    Zegers-Hochschild F, Dyer S, Adamson GD, et al.; incl. Elgindy E. Hum Reprod. 2026;41(6):892-909 · PMID 42100799

  2. International report2025
  3. International report2025

    International Committee for Monitoring Assisted Reproductive Technologies (ICMART): world report for cycles conducted in 2017–2018

    Baker VL, Dyer S, Chambers GM, Keller E, Banker M, de Mouzon J, Elgindy E, et al. Hum Reprod. 2025;40(6):1110-1126 · PMID 40239109

  4. International report2024

    International Committee for Monitoring Assisted Reproductive Technology world report: assisted reproductive technology, 2015 and 2016

    Kupka MS, Chambers GM, Dyer S, Zegers-Hochschild F, de Mouzon J, Ishihara O, Banker M, Jwa SC, Fu B, Elgindy E, Baker V, Adamson GD. Fertil Steril. 2024;122(5):875-893 · PMID 38996903

  5. Randomised controlled trial2022

    The novel incorporation of aromatase inhibitor in hormonal replacement therapy cycles: a randomized controlled trial

    Elgindy EA, Abdelghany AA, Sibai H, et al. Reprod Biomed Online. 2022;44(4):641-649 · PMID 35288021

  6. Randomised controlled trial2018

    Towards an optimal luteal support modality in agonist triggered cycles: a randomized clinical trial

    Elgindy EA, Sibai H, Mostafa MI, Gibreel A, Darwish E, Maghraby H. Hum Reprod. 2018;33(6):1079-1086 · PMID 29562260

  7. Systematic review2015

    Protecting ovaries during chemotherapy through gonad suppression: a systematic review and meta-analysis

    Elgindy E, Sibai H, Abdelghani A, Mostafa M. Obstet Gynecol. 2015;126(1):187-195 · PMID 26241272

  8. Randomised controlled trial2013

    Gonadotrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial

    Elgindy EA, El-Haieg DO, Khorshid OM, Ismail EI, Abdelgawad M, Sallam HN, Abou-Setta AM. Obstet Gynecol. 2013;121(1):78-86 · PMID 23262931

  9. Randomised controlled trial2011

    Blastocyst-stage versus cleavage-stage embryo transfer in women with high oestradiol concentrations: a randomized controlled trial

    Elgindy EA, Abou-Setta AM, Mostafa MI. Reprod Biomed Online. 2011;23(6):789-798 · PMID 22050864

All publications (34)
  1. International report2026

    The International Glossary on Infertility and Fertility Care, 2025

    Zegers-Hochschild F, Dyer S, Adamson GD, et al.; incl. Elgindy E. Hum Reprod. 2026;41(6):892-909 · PMID 42100799

  2. International report2026

    The International Glossary on Infertility and Fertility Care, 2025

    Zegers-Hochschild F, Dyer S, Adamson GD, et al.; incl. Elgindy E. Fertil Steril. 2026;126(1):127-149 · PMID 42106200

  3. International report2026

    Assisted reproductive technology in Africa: the African Network and Registry for ART, 2021 and 2022

    Dyer S, Potgieter L, Honwana F, et al.; incl. Elgindy E. Reprod Biomed Online. 2026;52(2):105230 · PMID 41483782

  4. International report2025
  5. International report2025

    International Committee for Monitoring Assisted Reproductive Technologies (ICMART): world report for cycles conducted in 2017–2018

    Baker VL, Dyer S, Chambers GM, Keller E, Banker M, de Mouzon J, Elgindy E, et al. Hum Reprod. 2025;40(6):1110-1126 · PMID 40239109

  6. International report2024

    International Committee for Monitoring Assisted Reproductive Technology world report: assisted reproductive technology, 2015 and 2016

    Kupka MS, Chambers GM, Dyer S, Zegers-Hochschild F, de Mouzon J, Ishihara O, Banker M, Jwa SC, Fu B, Elgindy E, Baker V, Adamson GD. Fertil Steril. 2024;122(5):875-893 · PMID 38996903

  7. International report2024

    Assisted reproductive technologies in Africa: The African Network and Registry for ART, 2020

    Archary P, Potgieter L, Honwana F, Elgindy E, et al. Reprod Biomed Online. 2024;49(5):104353 · PMID 39305801

  8. Systematic review2024

    Common Beverage Consumption and Benign Gynecological Conditions

    Michel R, Hazimeh D, Saad EE, Olson SL, Musselman K, Elgindy E, Borahay MA. Beverages (Basel). 2024;10(2):33 · PMID 38948304

  9. International report2023

    Assisted reproductive technologies in Africa: The African Network and Registry for ART, 2018 and 2019

    Archary P, Potgieter L, Elgindy E, et al. Reprod Biomed Online. 2023;46(5):835-845 · PMID 36959069

  10. Randomised controlled trial2022

    The novel incorporation of aromatase inhibitor in hormonal replacement therapy cycles: a randomized controlled trial

    Elgindy EA, Abdelghany AA, Sibai H, et al. Reprod Biomed Online. 2022;44(4):641-649 · PMID 35288021

  11. Conference abstract2020

    Does endometrial compaction on the day of frozen blastocyst transfer improve the outcome of frozen-thawed cycles? Interim analysis

    Elgindy EA, Abdelghany A, Sibai H, El-Haieg DO, Mostafa MI. Fertil Steril. 2020;114(3 Suppl):e317

  12. Randomised controlled trial2018

    Towards an optimal luteal support modality in agonist triggered cycles: a randomized clinical trial

    Elgindy EA, Sibai H, Mostafa MI, Gibreel A, Darwish E, Maghraby H. Hum Reprod. 2018;33(6):1079-1086 · PMID 29562260

  13. Systematic review2015

    Protecting ovaries during chemotherapy through gonad suppression: a systematic review and meta-analysis

    Elgindy E, Sibai H, Abdelghani A, Mostafa M. Obstet Gynecol. 2015;126(1):187-195 · PMID 26241272

  14. Randomised controlled trial2015

    Endometrial scratching for women with previous IVF failure undergoing IVF treatment

    Gibreel A, El-Adawi N, Elgindy E, Al-Inany H, Allakany N, Tournaye H. Gynecol Endocrinol. 2015;31(4):313-316 · PMID 25561347

  15. Randomised controlled trial2013

    Gonadotrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial

    Elgindy EA, El-Haieg DO, Khorshid OM, Ismail EI, Abdelgawad M, Sallam HN, Abou-Setta AM. Obstet Gynecol. 2013;121(1):78-86 · PMID 23262931

  16. Study2012
  17. Randomised controlled trial2011

    Blastocyst-stage versus cleavage-stage embryo transfer in women with high oestradiol concentrations: a randomized controlled trial

    Elgindy EA, Abou-Setta AM, Mostafa MI. Reprod Biomed Online. 2011;23(6):789-798 · PMID 22050864

  18. Conference abstract2011

    Are there detrimental cutoffs for progesterone and/or progesterone/estradiol ratio on the day of hCG administration among blastocyst transfers?

    Elgindy EA, Mostafa MI. Fertil Steril. 2011;96(3 Suppl):S65

  19. Study2011
  20. Randomised controlled trial2011
  21. Study2010

    N-acetyl cysteine: could it be an effective adjuvant therapy in ICSI cycles? A preliminary study

    Elgindy EA, El-Huseiny AM, Mostafa MI, Gaballah AM, Ahmed TA. Reprod Biomed Online. 2010;20(6):789-796 · PMID 20385511

  22. Randomised controlled trial2010

    Does luteal estradiol supplementation have a role in long agonist cycles?

    Elgindy EA, El-Haieg DO, Mostafa MI, Shafiek M. Fertil Steril. 2010;93(7):2182-2188 · PMID 19243745

  23. Study2010

    Is it beneficial to add N-acetyl cysteine to human menopausal gonadotrophin for controlled ovarian hyperstimulation and intrauterine insemination?

    Elgindy EA. Egypt J Fertil Steril. 2010;14:29-36

  24. Study2008
  25. Study2008

    Hysteroscopic tubal cannulation under laparoscopic guidance: a therapeutic approach to cases of bilateral proximal tubal blockage

    El-Haig DO, Hamouda A, Elgindy EA, Diab A, Abdelfatah T. ZUMJ. 2008;14(2):2137

  26. Study2006

    The impact of LH level on day one of ovarian stimulation and duration of stimulation on the outcome of ICSI cycles using the long agonist protocol

    Elgindy EA, Sharaf SM, Ragab H. Ain Shams Med J. 2006;57:167-180

  27. Study2006

    Single dose methotrexate therapy for ectopic pregnancy: pre- and post-treatment trend in serum hCG as predictors of treatment failure

    Elhaig DO, Elgindy EA, Sabry M. ZUMJ. 2006;10(1):15-21

  28. Study2005

    Hysteroscopic bipolar (VersaPoint) septal resection: initial experience

    Alhosiny A, Kasem G, Elgindy EA. ZUMJ. 2005;9(4):2087-2094

  29. Study2005

    Impact of maternal blood glucose on fetal growth and pregnancy complications

    Eisa S, Fahmy H, Elgindy EA, Sharaf S. ZUMJ. 2005;9(3):1368-1379

  30. Study2004

    Uterine receptivity: prediction and an approach for improvement

    Elgindy EA, Elhaig DO, Suilam S, Hafez EM. Ain Shams Med J. 2004;55:981-999

  31. Study2004

    Evaluation of uterine artery embolization in the management of symptomatic uterine fibroid

    Suilam S, Elwan Y, Elgindy EA. J Egypt Soc Obstet Gynecol. 2004;30:495-511

  32. Study2004

    Bacteria of nosocomial urinary tract infections at a university hospital in Egypt: identification and associated risk factors

    Amer FA, Mohtady HA, et al.; incl. Elgindy E. Infect Control Hosp Epidemiol. 2004;25(11):895-897 · PMID 15566017

  33. Study2003

    Prognostic value of P53 and KI67 expression in epithelial ovarian neoplasms: correlation with histopathology

    Salah S, George M, Elgindy EA, Elfar A. ZUMJ. 2003;9:81-97

  34. Conference abstract1999

    Correlation between oocyte morphology with fertilization rate and embryo quality in cases of intracytoplasmic sperm injection

    El-Gindy EA, El-Nahas F, Nasr A, et al. Hum Reprod. 1999;14:161

View all publications on PubMed

International books

  • Book · 2020

    Fibroid and Reproduction

    International book — London, UK

  • Book · 2014

    Fertility Preservation: Advances and Controversies

    Chapter: “Medical Approaches for Fertility Preservation in Female Cancer Patients”

Scientific leadership

  1. 2026

    Member of the EFRE International Working Group on Recurrent Implantation Failure good-practice recommendations

  2. Since 2020

    Director, Egypt IVF Registry

  3. Since 2019

    ICMART team member — elected by the ICMART governing board

  4. Since 2019

    Associate Editor, Middle East Fertility Society Journal

  5. 2024

    Led EFRE's official international collaborations with the American Society for Reproductive Medicine (ASRM) and the Mexican Congress of Reproductive Medicine (AMMR)

  6. 2024

    President, EFRE International Conference

  7. 2023

    Vice President, EFRE International Conference

  8. 2022

    General Secretary, EFRE International Conference

  9. 2019

    Founded the Egyptian Foundation for Reproductive Medicine and Embryology (EFRE), a non-profit organisation

Selected international talks

100+ lectures and contributions at international congresses and workshops since 1998 — recent highlights:

  1. 2026

    Opening speaker of the 6th EFRE International Conference, Cairo, and plenary lecture on recurrent implantation failure good-practice recommendations

  2. 2026

    Expert roundtable at the ASRM Scientific Congress (USA) on recurrent implantation failure, developed with SART, and a roundtable on poor responders

  3. 2026

    Lectures at the Middle East Fertility Society (MEFS) annual meeting and the Moroccan Society MSERM on frozen embryo transfer and implantation failure

  4. Oct 2025

    ASRM Scientific Congress, San Antonio, USA: postgraduate course “ART above 40”, and head of the roundtable on frozen embryo transfer optimisation

  5. Jul 2025

    Lecture and panel, annual meeting of the Mexican Congress of Reproductive Medicine (AMMR), Tulum, Mexico

  6. 2025

    Joint ASRM–EFRE and AMMR–EFRE international webinars on individualising ovarian stimulation

  7. Nov 2024

    MEFS annual meeting, Doha, Qatar: “Frozen ET Optimization: What is new in 2024?”

  8. May 2024

    Plenary at the EFRE International Conference: “A big data approach to ART in Egypt: lessons learned from more than 250,000 cycles”

Awards & honours

  1. 2012

    Certificate of Distinction in Medical Sciences — Zagazig University

  2. 2011

    Promoted to Professor of Obstetrics & Gynaecology with a score of 98/100 — all promotion research in assisted reproduction

  3. 2008

    Best Research in Human Reproduction Award — Middle East Fertility Society (MEFS)

  4. 2008–2011

    Certificates of Excellence from Zagazig University for contributions to the university's development

  5. 2005

    Certificate of Special Appreciation, Zagazig Faculty of Medicine, for helping the faculty achieve ISO 9001:2000 certification

  6. 1993

    Medal of the Egyptian Medical Syndicate

  7. 1991

    Graduated first in her class with Excellent and First-Class Honours — Zagazig University School of Medicine